| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 36 |
| 1 | IPILIMUMAB | 34 |
| 2 | PROGESTERONE | 21 |
| 3 | CARBOPLATIN | 17 |
| 4 | LEVONORGESTREL | 12 |
| 5 | ASPIRIN | 11 |
| 6 | ASPIRIN 325 MG | 11 |
| 7 | ASPIRIN 81 MG | 11 |
| 8 | PACLITAXEL | 10 |
| 9 | PREDNISOLONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INTERLEUKIN-10 | 2 | 0.0056 |
| 1 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 2 | TALIMOGENE LAHERPAREPVEC | 2 | 0.0013 |
| 3 | DUVELISIB | 1 | 0.0012 |
| 4 | PROGESTERONE | 21 | 0.0009 |
| 5 | IPILIMUMAB | 34 | 0.0008 |
| 6 | IBANDRONATE SODIUM | 2 | 0.0006 |
| 7 | TREMELIMUMAB | 2 | 0.0005 |
| 8 | NIVOLUMAB | 36 | 0.0004 |
| 9 | BISACODYL SUPPOSITORIES | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progesterone [EPC] | 21 | 0.0009 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 36 | 0.0007 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 56 | 0.0006 |
| 3 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 4 | Stimulant Laxative [EPC] | 3 | 0.0002 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 6 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 21 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |